Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilett

Showing results (321-330 of 369) with videos related to

Pageof 37
Sort By:
Blood Advances|November 24, 2020
Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipientsEmma E Ilett, Mette Jørgensen, Marc Noguera-Julian, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|October 26, 2020
Analysis of complex, beam-sensitive materials by transmission electron microscopy and associated techniquesMartha Ilett, Mark S'ari, Helen Freeman, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 7, 2009
Investigation of reproductive toxicity of piperaquine in miceKevin T Batty, Brioni R Moore, Verity Stirling, et al.
Nature Biotechnology|March 20, 2012
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanomaJose Pulido, Timothy Kottke, Jill Thompson, et al.
The Journal of Infectious Diseases|February 8, 2023
Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant RecipientsJens Christian Nørgaard, Mette Jørgensen, Kasper Sommerlund Moestrup, et al.
Gene Therapy|March 14, 2009
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunityE J Ilett, R J Prestwich, T Kottke, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malariaT T Hien, T M E Davis, L V Chuong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirusRobin J Prestwich, Fiona Errington, Lynette P Steele, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malariaT Q Binh, K F Ilett, K T Batty, et al.
Pageof 37

Showing results (321-330 of 369) with videos related to

Sort By:
Pageof 37
Blood Advances|November 24, 2020
Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipientsEmma E Ilett, Mette Jørgensen, Marc Noguera-Julian, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|October 26, 2020
Analysis of complex, beam-sensitive materials by transmission electron microscopy and associated techniquesMartha Ilett, Mark S'ari, Helen Freeman, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 7, 2009
Investigation of reproductive toxicity of piperaquine in miceKevin T Batty, Brioni R Moore, Verity Stirling, et al.
Nature Biotechnology|March 20, 2012
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanomaJose Pulido, Timothy Kottke, Jill Thompson, et al.
The Journal of Infectious Diseases|February 8, 2023
Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant RecipientsJens Christian Nørgaard, Mette Jørgensen, Kasper Sommerlund Moestrup, et al.
Gene Therapy|March 14, 2009
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunityE J Ilett, R J Prestwich, T Kottke, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malariaT T Hien, T M E Davis, L V Chuong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirusRobin J Prestwich, Fiona Errington, Lynette P Steele, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malariaT Q Binh, K F Ilett, K T Batty, et al.
Pageof 37